Authors
Jie Zhang, Jiale Zhu, Yinfang Xu, Pingting Xu, Rong Wang, Chen Yang, Chen Li, Dawei Zhang, Hongying Zhang
Published in
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. Nov 09, 2026. Epub Nov 09, 2026.
Abstract
Tuberculosis (TB) recurrence after successful treatment remains an important challenge for TB control. We characterized recurrence timing and associated factors among successfully treated pulmonary TB patients in Nanjing, China.
We conducted a retrospective cohort study using the Tuberculosis Management Information System. A total of 23,423 newly diagnosed pulmonary TB patients registered during 2011-2022 who achieved cure or treatment completion were followed from successful treatment until first recorded recurrence or 31 December 2022. Kaplan-Meier methods and log-rank tests were used to assess recurrence patterns and subgroup differences. Multivariable associations were evaluated using Cox regression; proportional hazards were assessed with scaled Schoenfeld residuals, and a time-varying coefficient was used for bacteriological positivity.
During 144,259.81 person-years of follow-up, 660 patients developed recurrent TB, giving a recurrence proportion of 2.82% and an incidence rate of 0.458 per 100 person-years (95% CI, 0.423-0.494). Among recurrent cases, 30.30%, 52.42%, and 87.27% occurred within 1, 2, and 5 years, respectively. Male sex, age ≥ 40 years, selected occupational categories, and non-migrant worker status were associated with higher recurrence hazards. For bacteriologically positive versus negative patients, the adjusted hazard ratio was 2.506 (95% CI, 2.009-3.127) during the first 2 years and 1.613 (95% CI, 1.289-2.019) thereafter.
TB recurrence was relatively uncommon but concentrated early after treatment. Enhanced post-treatment surveillance, particularly during the first 2 years, may facilitate earlier detection among higher-risk groups.
PMID:
43002376
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0